ProQR Therapeutics N.V (NASDAQ: PRQR) on Monday, plunged -5.99% from the previous trading day, before settling in for the closing price of $2.17. Within the past 52 weeks, PRQR’s price has moved between $1.07 and $3.10.
A company in the Healthcare sector has jumped its sales by 25.70% annually for the last half of the decade. The company achieved an average annual earnings per share of -29.25%. With a float of $70.02 million, this company’s outstanding shares have now reached $105.35 million.
ProQR Therapeutics N.V (PRQR) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of ProQR Therapeutics N.V is 33.45%, while institutional ownership is 35.10%.
ProQR Therapeutics N.V (PRQR) Latest Financial update
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.1 earnings per share (EPS) for the period topping the consensus outlook (set at -0.15) by 0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -29.25% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -21.54% during the next five years compared to 25.70% growth over the previous five years of trading.
ProQR Therapeutics N.V (NASDAQ: PRQR) Trading Performance Indicators
ProQR Therapeutics N.V (PRQR) is currently performing well based on its current performance indicators. A quick ratio of 3.36 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 12.59.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.46, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach -0.63 in one year’s time.
Technical Analysis of ProQR Therapeutics N.V (PRQR)
Let’s dig in a bit further. During the last 5-days, its volume was 0.49 million. That was better than the volume of 0.45 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 21.95%.
During the past 100 days, ProQR Therapeutics N.V’s (PRQR) raw stochastic average was set at 18.46%, which indicates a significant increase from 4.30% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.18 in the past 14 days, which was higher than the 0.18 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.33, while its 200-day Moving Average is $2.03. However, in the short run, ProQR Therapeutics N.V’s stock first resistance to watch stands at $2.20. Second resistance stands at $2.36. The third major resistance level sits at $2.45. If the price goes on to break the first support level at $1.95, it is likely to go to the next support level at $1.86. The third support level lies at $1.70 if the price breaches the second support level.
ProQR Therapeutics N.V (NASDAQ: PRQR) Key Stats
Market capitalization of the company is 214.63 million based on 105,213K outstanding shares. Right now, sales total 20,460 K and income totals -30,040 K. The company made 3,370 K in profit during its latest quarter, and -12,860 K in sales during its previous quarter.
